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Quality of Life following Percutaneous Transluminal Angioplasty for 
Claudication 
T. A. Cook, M. O'Regan and R. B. Galland 
Department of Surgery, Royal Berkshire Hospital, London Road, Reading, Berkshire, RG1 5AN, U.K. 
Objective: To determine quality of life in claudicants before and after percutaneous transluminal ngioplasty (PTA). 
Design: Prospective study using EuroQuol questionnaire and visual analogue scales. 
Setting: District general hospital 
Materials: Twenty-nine patients undergoing successful PTA. 
Results: Before PTA patients howed asignificantly lower EuroQuol score compared with the normal population. There 
was also marked impairment of patients usual activities, mobility and perceived health state. Following successful PTA the 
EuroQuol score, perceived health state, mobility, usual activities, pain and discomfort and mental state were all 
significantly improved. 
Conclusions: Intermittent claudication impairs quality of life. Following successful PTA there is significant improvement 
in symptoms and in general health. 
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Introduction Methods 
Following revascularisation procedures for peripheral 
vascular disease, ankle-brachial pressure indices, 
walking distance and vessel patency are all simple 
quantitative measures of outcome. Intermittent claudi- 
cation is essentially a benign condition with few 
patients progressing to limb threatening ischaemia. ~'2 
Percutaneous transluminal angioplasty (PTA) has now 
become the treatment of choice for symptomatic 
claudication. PTA is associated with a low morbidity. 3 
Initial success and patency depend upon the nature 
and site of lesion treated. Five year patency ~ates of 
80-90% following dilatation of iliac lesions have been 
reported. Femoropopliteal lesions on the other hand 
have patency rates of only 60-70% at 5 years. 4'5 
However, to the individual concerned, quality of life 
following revascularisation is far more important than 
vessel patency. Whilst some studies have attempted to 
define quality of life following surgical reconstruction 
and amputation, 6-8 little is known about the effect of 
PTA on subsequent quality of life. The aim of this 
study was to assess quality of life in patients with 
intermittent claudication before and after PTA. 
Please~address all correspondence to: Mr R. B. Galland. 
Over a 3 month period patients undergoing PTA for 
unilateral claudication were assessed with regard to 
their walking distance and quality of life. Ques- 
tionnaires were completed at the time of admission to 
hospital for PTA and in the outpatient clinic 6 weeks 
later. Patients with critical ischaemia nd those under- 
going PTA prior to another procedure were 
excluded. 
Walking distance was assessed using a previously 
validated questionnaire. 9 Patients were asked to grade 
their walking ability from 0 (did not walk), through to 
3 (no problem) (Table 1). Distances ranging from 10 m 
to 500m were assessed. By multiplying the distance 
with the grading, a score is produced which is 
expressed as a percentage of the maximum. 
Quality of life was assessed using a EuroQuol 
questionnaire and visual analogue scales. The Euro- 
Quol system is a European method of assessment in
which six factors are studied that contribute to health 
state. 1° These are mobility, ability to self care, ability to 
work, ability to perform leisure activities, pain/ 
discomfort and anxiety/depression. The results from 
each modality are combined to generate a single index 
for each health state (Table 2). A total of 216 health 
states exist and scores have been attached to each of 
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Table 1. Walking impairment questionnaire. Scores for each 
distance were multiplied by the weighting score. The value 
obtained was divided by the maximum possible (3540) to give a 
fraction which was compared before and after treatment 
Degree of difficulty 
No Some Much Did not do Score 
weight (m) 
Walking indoors 3 2 1 0 10 
Walking 20 m 3 2 1 0 20 
Walking 50 m 3 2 1 0 50 
Walking 100 m 3 2 1 0 100 
Walking 200 m 3 2 1 0 200 
Walking 300 m 3 2 1 0 300 
Walking 500 m 3 2 1 0 500 
Question: For each of the following distances report he degree of 
difficulty that best describes how hard it was for you to walk without 
stopping to rest. 
Table 2. EuroQol Descriptive Classification. Values based on 
questionnaires completed by sample populations have been 
attached to each subgroup. These scores are subtracted from a 
maximum of 91.8 to give a single index 
Mobility 
1. No problems walking about 
2. Unable to walk without a stick, crutch or walking frame 
3. Confined to bed 
Self-care 
1. No problems with self care 
2. Unable to dress elf 
3. Unable to feed self 
Main activity 
1. Able to perform ma~n activity (e.g. work, study, housework) 
2. Unable to perform main activity 
Social relationships 
1. Able to pursue family and leisure activities 
2. Unable to pursue family and leisure activities 
Pain 
1. No pain or discomfort 
2. Moderate pain or discomfort 
3. Extreme pain or discomfort 
Mood 
1. Not anxious or depressed 
2. Anxious or depressed 
these reflecting responses from sample populations. 
The original EuroQuol system was used in this study 
although refinement of the questionnaire is 
ongoing. 1~ 
Visual analogue scales (VAS) were used to assess 
similar modalities. Walking distances and quality of 
life scores were compared before and after PTA. 
Statistical analysis was performed using a paired 
Student's t-test. 
Results 
Questionnaires were easy to complete although many 
patients needed some assistance particularly with the 
walking assessment. Data retrieval was performed on 
the ward or in clinic and could be completed in 10 
min. Thirty five patients underwent PTA for unilateral 
claudication during the study period. Two of these 
patients had acute thromboses within 24 h of angio- 
plasty which were not cleared with thrombolysis. Both 
underwent successful surgical reconstruction during 
the same admission. Thirty three patients had radi- 
ologically successful angioplasty. Three failed to 
attend clinic despite two reminder letters. A further 
man refused to complete a questionnaire when seen 6 
weeks later. There were thus 29 patients (mean age 65 
years, 14 men, 15 women) who completed a second 
questionnaire at follow-up. Six patients had iliac 
lesions, 20 femoropopliteal lesions and three had both. 
The results before and after treatment are shown in 
Table 3. The only parameter which was not reduced 
before PTA compared with the normal population was 
self care. All of the other parameters were significantly 
improved following angioplasty. 
Five patients complained that their symptoms had 
not been improved by PTA. Their walking scores and 
changes in quality of life parameters howed no 
significant difference following attempted revascular- 
isation. All five had had femoropopliteal ngioplasty 
and subsequent angiography showed restenosis of the 
original lesions in all cases. 
Discussion 
Quality of life in patients with critical l imb ischaemia 
may be improved both with amputat ion and vascular 
reconstruction. However, improvement in quality of 
life in patients undergoing revascularisation is greater 
than in those having an amputation. 12 This is one 
argument for an aggressive policy towards limb 
salvage. Another is the overall cost of amputat ion 
compared with revascularisation when rehabilitation 
and increased hospital stay are considered. 13 
Quality of life scores in patients with intermittent 
claudication, whilst reduced compared with normal, 
are not as low as those with critical ischaemia. 12 With 
increasing pressure on resources, health care manag- 
ers are interested in benefits of treatment in relation to 
cost of procedures. In addition, patients are less 
interested in whether or not a vessel is patent, than in 
the effect that patency has on their life style. Inter- 
mittent claudication is a relatively benign disease with 
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Table 3. Walking distance, EuroQol and VAS scores before and after PTA 
Pre-PTA Post-PTA 
Mean (S.D.) Mean (S.D.) 
Walking distance score 0.29 (0.22) 
EuroQol Score 78.9 (11.1) 
Visual analogue scales: 
Perceived health state 74.3 (18.5) 
(0=worst, 100=best) 
Mobility 71.3 (16.3) 
(0=bed bound, 100=no problem) 
Self care 96.5 (7.9) 
(0=totally dependent, 100=no problem) 
Usual activities 64.8 (16.7) 
(0=unable toperform, 100=no problem) 
Pain/discomfort 46.8 (23.1) 
(0=pain free, 100=constant, extreme) 
Anxiety/depression 14.1 (18.5) 
(0=none, 100=constant, severe) 
0.71 (0.31) t=6.96 d.f.=28p<0.001 
85.8 (8.1) t=3.25 d.f.=28p<0.01 
86.1 (10.3) t=5.29 d.f.=28p<0.001 
86.0 (13.6) t=4.80 d.f.=28p<0.001 
97.7 (5.7) t=1.12 d.f.=28 p=NS 
84.7 (16.9) t=6.12 d.f.=28p<0.001 
24.3 (18.5) t=5.50 d.f.=28p<0.001 
5.7 (8.6) t=2.57 d.f.=28 p<0.02 
few patients progressing to critical limb ischaemia. 1'2 
The main justification for treatment therefore is relief 
of symptoms. However, if treatment enables an 
individual to return to work it will have wider ranging 
economic implications. 
Numerous methods of assessing quality of life exist. 
It was the intention in this study to use a method that 
could if necessary be completed by the patient alone. 
The EuroQuol system was designed to be a form for 
self-completion and gives a single value which is 
easily comparable. The fact that there are a maximum 
of only three categories in each modality may cause 
problems when comparing a variety of disease 
states. 14 For example, pain due to varicose veins is not 
the same as pain due to ischaemia. However, within 
the same group of patients with similar disease 
patterns comparison is valid. The EuroQuol system 
has also been criticised for potentially being inaccurate 
if the scores before and after treatment are grouped at 
the upper end of the scale. It may be most accurate in 
assessing interventions associated with large scale 
health improvements. 11"15 The improvement in walk- 
ing distance with successful PTA demonstrated in this 
study supports the validity of its use. In conjunction 
with the VAS it provided a simple method of assessing 
quality of life. 
The perceived health state on VAS and EuroQuol 
score correlates well in terms of improvement post- 
PTA. There was no difference in the ability to self care 
following the procedure. This is not surprising in that 
the population selected for treatment is relatively 
mobile when compared with patients with critical 
ischaemia. This is reflected in the high scores prior to 
angioplasty. The slight improvement in anxiety state 
can be explained by admission to hospital at the time 
of completion of the first questionnaire. Whilst 
patients were encouraged to give an impression of 
their anxiety state prior to admission there is no doubt 
that the thought of admission to hospital for an 
invasive procedure would have some bearing on the 
responses obtained. However, the benefits of PTA 
were reflected in the significant improvements dem- 
onstrated in perceived health state, mobility, pain 
control and ability to perform usual activities. 
Clinical impression correlated well with results. In 
the five patients with no significant improvement in 
walking distance there was no improvement in quality 
of life. Despite this, the group as a whole (including 
these five) showed significant improvements follow- 
ing PTA. 
Intermittent claudication impairs quality of life. The 
risks of any procedure should be balanced against he 
benefits and potential side-effects oftreatment must be 
acceptable to the patient. PTA is a relatively low risk 
procedure. This study has demonstrated a significant 
improvement in quality of life following PTA. PTA is 
a relatively low cost procedure 16 and may be per- 
formed with an overnight stay or even as a day case. 
The low cost and significant quality of life improve- 
ments support the continued use of PTA in the 
management of intermittent claudication. 
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